Kenneth E. Jenkins, PhD
Member / Co-Chair, Intellectual Property Prosecution and Counseling Practice
+1.858.314.1082
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Ken has extensive experience in patenting a wide range of life sciences technologies, including antibody therapeutics, small molecule modulators, diagnostics, immuno-oncotherapies, pharmaceutical formulations, gene editing, siRNA therapeutics, stem cell therapies, nanotechnologies, and machine learning and AI in life sciences technologies. He enjoys working closely with scientists to translate their discoveries to high-value patent assets.
Ken works with a diverse set of clients, from research institutions to pre-funded startups to some of the world’s largest life sciences companies. He carefully tailors patent strategies to the specific business needs of each client while considering the ever-changing global patent case law landscape.
viewpoints
How Can the Updated USPTO Guidance on Determining Obviousness Help You?
March 7, 2024 | Blog | By Peter Hecker, PhD, Jenny Chen, PhD, Ken Jenkins, Christina Sperry
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness
February 17, 2021 | Blog | By Ken Jenkins
Year in Review: The Most Popular IP Posts of 2020
January 14, 2021 | Blog | By Christina Sperry
Federal Circuit Awards Attorney Fees to the Defendant Following Dismissal of Lawsuit by Plaintiff
January 7, 2020 | Blog | By Ken Jenkins
Copy Cats: Evidence of Copying a Specific Product NOT Required
November 12, 2019 | Blog | By Ken Jenkins
Prior Civil Action Bars IPR - A precedential decision
September 24, 2019 | Blog | By Ken Jenkins
Under New Guidance: Patent Eligibility of Computerized Diagnostics at the PTAB
May 15, 2019 | Blog | By Ken Jenkins
Prosecution Strategies for Avoiding Patent Eligibility Rejections for Diagnostics
November 19, 2018 | Blog | By Ken Jenkins
Inventorship
August 27, 2018 | Video | By Ken Jenkins
News & Press
Mintz Attorneys Recognized in Managing IP’s 2025 IP Stars
June 13, 2025|
Mintz IP Practice Recognized in 2025 IAM Patent 1000
June 2, 2025|
Mintz IP Practice Recognized in 2024 IAM Patent 1000
June 18, 2024|
Pharma Refines Tricks To Tackle Section 112 But Left Frustrated
October 14, 2022|
Why Counsel Should Watch Novartis SCOTUS Appeal
September 22, 2022|
How USPTO Pharma Reform Could Lower Counsel Spend
July 15, 2022|
Mintz Shortlisted for 3 Managing Intellectual Property Americas Awards 2022
February 17, 2022|
Seven Mintz Attorneys Recognized as 2021 San Diego Super Lawyers
March 31, 2021|
One Hundred Mintz Attorneys Ranked as Leaders by Best Lawyers 2020
August 15, 2019|
49 Mintz Attorneys Featured in Chambers USA 2016 Guide
May 31, 2016|
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Recognition & Awards
Best Lawyers in America: Patent Law (2017 – 2027); Lawyer of the Year for Patent Law (2021, 2024)
Managing Intellectual Property: Patent Star – California (2016 – 2026)
Recognized in Chambers USA: California – Intellectual Property: Patent Prosecution (2016, 2017, 2021 – 2026)
IAM Patent 1000: World's Leading Patent Practitioners (2016, 2017, 2019 – 2026)
San Diego Business Journal: Leader of Influence in Life Sciences (2023 – 2024); Leaders in Law Award finalist (2021)
San Diego Super Lawyers: Intellectual Property Law (2019 – 2023)
Southern California Super Lawyers: Intellectual Property Law (2013 – 2017)
Daily Journal: Top IP Lawyers (2020)
Legal 500 United States: Recommended for Healthcare: Life Sciences (2020)
San Diego Business Journal: Best of the Bar (2014 – 2015)
San Diego Daily Transcript: “Transcript 10” attorney, Top Attorneys (2012); Best Young Attorney (2008)
Young Investigator Award, Royal Society of Chemistry
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Involvement
- Past President, San Diego Intellectual Property Law Association
- Member, BIOCOM Intellectual Property Committee
Recent Insights
